6.
Bagcchi S
. WHO's Global Tuberculosis Report 2022. Lancet Microbe. 2022; 4(1):e20.
DOI: 10.1016/S2666-5247(22)00359-7.
View
7.
Pathak S, Basu S, Basu K, Banerjee A, Pathak S, Bhattacharyya A
. Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol. 2007; 8(6):610-8.
DOI: 10.1038/ni1468.
View
8.
Brooks M, Rajaram M, Azad A, Amer A, Valdivia-Arenas M, Park J
. NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cell Microbiol. 2010; 13(3):402-18.
PMC: 3259431.
DOI: 10.1111/j.1462-5822.2010.01544.x.
View
9.
Orme I, Robinson R, Cooper A
. The balance between protective and pathogenic immune responses in the TB-infected lung. Nat Immunol. 2014; 16(1):57-63.
DOI: 10.1038/ni.3048.
View
10.
Wang J, Li B, Ge P, Li J, Wang Q, Gao G
. Mycobacterium tuberculosis suppresses innate immunity by coopting the host ubiquitin system. Nat Immunol. 2015; 16(3):237-45.
DOI: 10.1038/ni.3096.
View
11.
Kim J, Kim W, Choi H, Kim H, Kwon K, Han S
. Mycobacterium tuberculosis MmsA, a novel immunostimulatory antigen, induces dendritic cell activation and promotes Th1 cell-type immune responses. Cell Immunol. 2015; 298(1-2):115-25.
DOI: 10.1016/j.cellimm.2015.10.005.
View
12.
Low T, Syafruddin S, Mohtar M, Vellaichamy A, Rahman N, Pung Y
. Recent progress in mass spectrometry-based strategies for elucidating protein-protein interactions. Cell Mol Life Sci. 2021; 78(13):5325-5339.
PMC: 8159249.
DOI: 10.1007/s00018-021-03856-0.
View
13.
Etna M, Giacomini E, Severa M, Coccia E
. Pro- and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis. Semin Immunol. 2014; 26(6):543-51.
DOI: 10.1016/j.smim.2014.09.011.
View
14.
Salvador-Martin S, Raposo-Gutierrez I, Navas-Lopez V, Gallego-Fernandez C, Moreno-Alvarez A, Solar-Boga A
. Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease. Int J Mol Sci. 2020; 21(9).
PMC: 7247673.
DOI: 10.3390/ijms21093364.
View
15.
Jordao L, Bleck C, Mayorga L, Griffiths G, Anes E
. On the killing of mycobacteria by macrophages. Cell Microbiol. 2007; 10(2):529-48.
DOI: 10.1111/j.1462-5822.2007.01067.x.
View
16.
Kleinnijenhuis J, Oosting M, Joosten L, Netea M, van Crevel R
. Innate immune recognition of Mycobacterium tuberculosis. Clin Dev Immunol. 2011; 2011:405310.
PMC: 3095423.
DOI: 10.1155/2011/405310.
View
17.
Wu X, Wu Y, Zheng R, Tang F, Qin L, Lai D
. Sensing of mycobacterial arabinogalactan by galectin-9 exacerbates mycobacterial infection. EMBO Rep. 2021; 22(7):e51678.
PMC: 8256295.
DOI: 10.15252/embr.202051678.
View
18.
Kim K, An D, Song J, Yoon J, Kim H, Yoon H
. Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7. Proc Natl Acad Sci U S A. 2012; 109(20):7729-34.
PMC: 3356628.
DOI: 10.1073/pnas.1120251109.
View
19.
Liu C, Liu H, Ge B
. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol. 2017; 14(12):963-975.
PMC: 5719146.
DOI: 10.1038/cmi.2017.88.
View
20.
Qiang L, Wang J, Zhang Y, Ge P, Chai Q, Li B
. Mycobacterium tuberculosis Mce2E suppresses the macrophage innate immune response and promotes epithelial cell proliferation. Cell Mol Immunol. 2018; 16(4):380-391.
PMC: 6461940.
DOI: 10.1038/s41423-018-0016-0.
View